Deciphering Exosomes at MD Anderson Cancer Center

Update: 2017-09-18 20:45:00

Professor Raghu Kalluri is interested in identifying the physiological function of exosomes and their role in disease states such as cancer. He has been a pioneer in exosomes research. In the past few years, the Kalluri laboratory unraveled new biology associated with exosomes. They have published two Nature articles, demonstrating the powerful applications of exosomes in the diagnosis and treatment of pancreatic cancer.

 The Kalluri laboratory recently acquired a NanoFCM system to characterize exosomes size, concentration, and biochemical properties. Given the difficulties with single exosomes phenotyping, NanoFCM provides a versatile platform for accurate and reproducible results. The Flow NanoAnalyzer gives insights not possible with other single particle detection methods. Precise particle size, particle concentration and biochemical property evaluation are essential to his project. We look forward to great research from Prof. Kalluri’s Group.

 For more than 75 years, MD Anderson has been a global leader in the fight to end cancer. MD Anderson has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey. MD Anderson ranks first in the number and amount of research grants awarded by the National Cancer Institute.


On ABreakthrough in Liquid Biopsy for Colorectal Cancer Diagnosis
NextImproving Exosomes Characterization at Codiak BioSciences